Hyperventilation in Patients With Traumatic Brain Injury

January 29, 2019 updated by: University of Zurich

Effects of Moderate Hyperventilation on Cerebral Hemodynamics, Oxygenation and Metabolism in Patients With Severe Traumatic Brain Injury

Elevated intracranial pressure is a dangerous and potentially fatal complication after traumatic brain injury. Hyperventilation is a medical intervention to reduce elevated intracranial pressure by inducing cerebral vasoconstriction, which might be associated to cerebral ischemia and hypoxia.

The main hypothesis is that a moderate degree of hyperventilation is sufficient to reduce the intracranial pressure without inducing cerebral ischemia.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In patients with severe traumatic brain injury (TBI), and with intracranial pressure-monitoring, brain tissue oxygen tension and/or microdialysis probes hyperventilation-tests are performed in the acute phase after trauma. Data are collected and TCCD measurements are performed at baseline, at the beginning of moderate hyperventilation, after prolonged moderate hyperventilation (for 50 minutes) and after return to baseline.

The present study aims to quantify potential adverse effects of moderate short-term hyperventilation during the acute phase of the severe TBI on cerebral hemodynamics, oxygenation, and metabolism.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zürich, Switzerland, 8006
        • University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • nonpenetrating traumatic brain injury
  • Glasgow coma scale <9 at presentation
  • Intracranial pressure monitoring
  • brain tissue oxygen tension monitoring and/or microdialysis monitoring
  • invasive mechanical ventilation with FIO2 <60% and PEEP <15 mbar

Exclusion Criteria:

  • decompressive craniectomy
  • pregnancy
  • pre-existing neurological disease
  • previous traumatic brain injury
  • acute cardiovascular disease
  • severe respiratory failure
  • acute on chronic liver disease
  • sepsis
  • failure to obtain satisfactory bilateral TCCD signals
  • persisting hypovolemia or hemodynamic instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: patients with severe TBI
Patients with severe TBI enrolled in the study undergo an hyperventilation test, in which the alveolar ventilation is increased by a stepwise increase in tidal volumes and respiratory rate until a reduction of etCO2 of 0.7 kPa is achieved.
Increase of the alveolar ventilation by a stepwise increase in tidal volumes and respiratory rate until a reduction of end-tidal CO2 of 0.7 kPa is achieved

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intracranial pressure
Time Frame: 10, 20, 50, 60 minutes after begin of the hyperventilation test
Change of intracranial pressure during moderate hyperventilation
10, 20, 50, 60 minutes after begin of the hyperventilation test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cerebral flow velocity in the middle cerebral artery
Time Frame: 20, 50, 60 minutes after begin of the hyperventilation test
Change of cerebral flow velocity during moderate hyperventilation
20, 50, 60 minutes after begin of the hyperventilation test
brain tissue oxygenation (PbrO2)
Time Frame: 10, 20, 50, 60 minutes after begin of the hyperventilation test
no changes
10, 20, 50, 60 minutes after begin of the hyperventilation test
cerebral Lactate/ Pyruvate ratio
Time Frame: 1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test
no changes
1 hour before initiation of the hyperventilation test, and 1 and 2 hours after begin of the hyperventilation test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Steiger, MD, University of Zurich

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2014

Primary Completion (Actual)

May 2, 2017

Study Completion (Actual)

May 2, 2017

Study Registration Dates

First Submitted

January 22, 2019

First Submitted That Met QC Criteria

January 29, 2019

First Posted (Actual)

January 30, 2019

Study Record Updates

Last Update Posted (Actual)

January 30, 2019

Last Update Submitted That Met QC Criteria

January 29, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperventilation

Clinical Trials on Hyperventilation test

Subscribe